{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:33:06Z","timestamp":1792801986711,"version":"4.5.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T00:00:00Z","timestamp":1504310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Utrecht"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12016-017-8636-1","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T02:49:29Z","timestamp":1504320569000},"page":"312-331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist\u2019s, Clinician\u2019s, and Patient\u2019s Perspective"],"prefix":"10.1007","volume":"55","author":[{"given":"Marta","family":"Cossu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Mosterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J. H.","family":"de Hair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R. D. J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,2]]},"reference":[{"issue":"2","key":"8636_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/BOR.0000000000000027","volume":"26","author":"M Nikpour","year":"2014","unstructured":"Nikpour M, Baron M (2014) Mortality in systemic sclerosis: lessons learned from population-based and observational cohort studies. Curr Opin Rheumatol 26(2):131\u2013137. doi:\n                    10.1097\/BOR.0000000000000027","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"8636_CR2","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Muller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumanovics G, Coleiro B, Feierl E, Szucs G, Von Muhlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kotter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809\u20131815. doi:\n                    10.1136\/ard.2009.114264","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8636_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12891-017-1603-4","volume":"18","author":"L Mouthon","year":"2017","unstructured":"Mouthon L, Alami S, Boisard AS, Chaigne B, Hachulla E, Poiraudeau S (2017) Patients\u2019 views and needs about systemic sclerosis and its management: a qualitative interview study. BMC Musculoskelet Disord 18(1):230. doi:\n                    10.1186\/s12891-017-1603-4","journal-title":"BMC Musculoskelet Disord"},{"issue":"8","key":"8636_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/acr.20187","volume":"62","author":"BD Thombs","year":"2010","unstructured":"Thombs BD, van Lankveld W, Bassel M, Baron M, Buzza R, Haslam S, Haythornthwaite JA, Hudson M, Jewett LR, Knafo R, Kwakkenbos L, Malcarne VL, Milette K, Motivala SJ, Newton EG, Nielson WR, Pacy M, Razykov I, Schieir O, Taillefer S, Worron-Sauve M (2010) Psychological health and well-being in systemic sclerosis: state of the science and consensus research agenda. Arthritis Care Res 62(8):1181\u20131189. doi:\n                    10.1002\/acr.20187","journal-title":"Arthritis Care Res"},{"issue":"11","key":"8636_CR5","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/acr.23207","volume":"69","author":"Daniel Sumpton","year":"2017","unstructured":"Sumpton D, Thakkar V, O'Neill S, Singh-Grewal D, Craig JC, Tong A (2017) \u201cIt\u2019s not me, it\u2019s not really me.\u201d Insights from patients on living with systemic sclerosis: an interview study. Arthritis Care Res. doi:\n                    10.1002\/acr.23207","journal-title":"Arthritis Care & Research"},{"issue":"7","key":"8636_CR6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3899\/jrheum.151309","volume":"43","author":"A Nakayama","year":"2016","unstructured":"Nakayama A, Tunnicliffe DJ, Thakkar V, Singh-Grewal D, O\u2019Neill S, Craig JC, Tong A (2016) Patients\u2019 perspectives and experiences living with systemic sclerosis: a systematic review and thematic synthesis of qualitative studies. J Rheumatol 43(7):1363\u20131375. doi:\n                    10.3899\/jrheum.151309","journal-title":"J Rheumatol"},{"issue":"12","key":"8636_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrrheum.2015.116","volume":"11","author":"LH Tuyl van","year":"2015","unstructured":"van Tuyl LH, Boers M (2015) Patient-reported outcomes in core domain sets for rheumatic diseases. Nat Rev Rheumatol 11(12):705\u2013712. doi:\n                    10.1038\/nrrheum.2015.116","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"8636_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/annrheumdis-2014-206485","volume":"74","author":"I Castrejon","year":"2015","unstructured":"Castrejon I, Gossec L, Carmona L (2015) The EULAR Outcome Measures Library: an evolutional database of validated patient-reported instruments. Ann Rheum Dis 74(2):475\u2013476. doi:\n                    10.1136\/annrheumdis-2014-206485","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8636_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.semarthrit.2016.10.002","volume":"46","author":"F Ingegnoli","year":"2017","unstructured":"Ingegnoli F, Carmona L, Castrejon I (2017) Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: an evolutional database model of validated patient-reported outcomes. Semin Arthritis Rheum 46(5):609\u2013614. doi:\n                    10.1016\/j.semarthrit.2016.10.002","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"8636_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","volume":"10","author":"YY Ho","year":"2014","unstructured":"Ho YY, Lagares D, Tager AM, Kapoor M (2014) Fibrosis\u2014a lethal component of systemic sclerosis. Nat Rev Rheumatol 10(7):390\u2013402. doi:\n                    10.1038\/nrrheum.2014.53","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"8636_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","volume":"10","author":"JC Broen","year":"2014","unstructured":"Broen JC, Radstake TR, Rossato M (2014) The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 10(11):671\u2013681. doi:\n                    10.1038\/nrrheum.2014.128","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"8636_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00420-009-0505-7","volume":"83","author":"ZD McCormic","year":"2010","unstructured":"McCormic ZD, Khuder SS, Aryal BK, Ames AL, Khuder SA (2010) Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int Arch Occup Environ Health 83(7):763\u2013769. doi:\n                    10.1007\/s00420-009-0505-7","journal-title":"Int Arch Occup Environ Health"},{"issue":"2","key":"8636_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","volume":"13","author":"I Marie","year":"2014","unstructured":"Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, Bravard P, Noel D, Cailleux AF, Weber J, Lagoutte P, Benichou J, Levesque H (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13(2):151\u2013156. doi:\n                    10.1016\/j.autrev.2013.10.002","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8636_CR14","first-page":"97","volume":"34","author":"A Kettaneh","year":"2007","unstructured":"Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Toledano C, Fabre B, Fardet L, Cabane J (2007) Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheumatol 34(1):97\u2013103","journal-title":"J Rheumatol"},{"key":"8636_CR15","first-page":"155","volume":"141","author":"WJ Nicholson","year":"1984","unstructured":"Nicholson WJ, Henneberger PK, Seidman H (1984) Occupational hazards in the VC-PVC industry. Prog Clin Biol Res 141:155\u2013175","journal-title":"Prog Clin Biol Res"},{"issue":"5","key":"8636_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00000372-200110000-00001","volume":"23","author":"SE Cowper","year":"2001","unstructured":"Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23(5):383\u2013393","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"8636_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1346-8138.2011.01301.x","volume":"39","author":"M Inaoki","year":"2012","unstructured":"Inaoki M, Kawabata C, Nishijima C, Yoshio N, Kita T (2012) Case of bleomycin-induced scleroderma. J Dermatol 39(5):482\u2013484. doi:\n                    10.1111\/j.1346-8138.2011.01301.x","journal-title":"J Dermatol"},{"issue":"1","key":"8636_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0190-9622(80)80292-1","volume":"2","author":"RF Palestine","year":"1980","unstructured":"Palestine RF, Millns JL, Spigel GT, Schroeter AL (1980) Skin manifestations of pentazocine abuse. J Am Acad Dermatol 2(1):47\u201355","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"8636_CR19","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s00296-012-2585-z","volume":"33","author":"M Radic","year":"2013","unstructured":"Radic M, Kaliterna DM, Bonacin D, Vergles JM, Radic J, Fabijanic D, Kovacic V (2013) Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int 33(11):2943\u20132948. doi:\n                    10.1007\/s00296-012-2585-z","journal-title":"Rheumatol Int"},{"issue":"5","key":"8636_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000232945","volume":"52","author":"K Zakrzewska","year":"2009","unstructured":"Zakrzewska K, Corcioli F, Carlsen KM, Giuggioli D, Fanci R, Rinieri A, Ferri C, Azzi A (2009) Human parvovirus B19 (B19V) infection in systemic sclerosis patients. Intervirology 52(5):279\u2013282. doi:\n                    10.1159\/000232945","journal-title":"Intervirology"},{"issue":"1","key":"8636_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.0303-6987.2003.0143.x","volume":"31","author":"CM Magro","year":"2004","unstructured":"Magro CM, Nuovo G, Ferri C, Crowson AN, Giuggioli D, Sebastiani M (2004) Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 31(1):43\u201350","journal-title":"J Cutan Pathol"},{"issue":"10","key":"8636_CR22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/80533","volume":"6","author":"C Lunardi","year":"2000","unstructured":"Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6(10):1183\u20131186. doi:\n                    10.1038\/80533","journal-title":"Nat Med"},{"issue":"4","key":"8636_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/jid.2013.423","volume":"134","author":"A Farina","year":"2014","unstructured":"Farina A, Cirone M, York M, Lenna S, Padilla C, McLaughlin S, Faggioni A, Lafyatis R, Trojanowska M, Farina GA (2014) Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma. J Invest Dermatol 134(4):954\u2013964. doi:\n                    10.1038\/jid.2013.423","journal-title":"J Invest Dermatol"},{"issue":"1","key":"8636_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13075-017-1237-9","volume":"19","author":"A Farina","year":"2017","unstructured":"Farina A, Peruzzi G, Lacconi V, Lenna S, Quarta S, Rosato E, Vestri AR, York M, Dreyfus DH, Faggioni A, Morrone S, Trojanowska M, Farina GA (2017) Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Arthritis Res Ther 19(1):39. doi:\n                    10.1186\/s13075-017-1237-9","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"8636_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrrheum.2016.68","volume":"12","author":"S Abdollahi-Roodsaz","year":"2016","unstructured":"Abdollahi-Roodsaz S, Abramson SB, Scher JU (2016) The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol 12(8):446\u2013455. doi:\n                    10.1038\/nrrheum.2016.68","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"8636_CR26","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/art.39572","volume":"68","author":"ER Volkmann","year":"2016","unstructured":"Volkmann ER, Chang YL, Barroso N, Furst DE, Clements PJ, Gorn AH, Roth BE, Conklin JL, Getzug T, Borneman J, McGovern DP, Tong M, Jacobs JP, Braun J (2016) Association of systemic sclerosis with a unique colonic microbial consortium. Arthritis Rheumatol 68(6):1483\u20131492. doi:\n                    10.1002\/art.39572","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8636_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13075-016-1182-z","volume":"18","author":"K Andreasson","year":"2016","unstructured":"Andreasson K, Alrawi Z, Persson A, Jonsson G, Marsal J (2016) Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease. Arthritis Res Ther 18(1):278. doi:\n                    10.1186\/s13075-016-1182-z","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8636_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2010.02.001","volume":"35","author":"RK Arora-Singh","year":"2010","unstructured":"Arora-Singh RK, Assassi S, del Junco DJ, Arnett FC, Perry M, Irfan U, Sharif R, Mattar T, Mayes MD (2010) Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun 35(1):52\u201357. doi:\n                    10.1016\/j.jaut.2010.02.001","journal-title":"J Autoimmun"},{"issue":"7","key":"8636_CR29","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA Jr, Wright TM (2003) Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 48(7):1956\u20131963. doi:\n                    10.1002\/art.11173","journal-title":"Arthritis Rheum"},{"key":"8636_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2015.07.005","volume":"64","author":"L Bossini-Castillo","year":"2015","unstructured":"Bossini-Castillo L, Lopez-Isac E, Martin J (2015) Immunogenetics of systemic sclerosis: defining heritability, functional variants and shared-autoimmunity pathways. J Autoimmun 64:53\u201365. doi:\n                    10.1016\/j.jaut.2015.07.005","journal-title":"J Autoimmun"},{"issue":"5","key":"8636_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/ng.565","volume":"42","author":"TR Radstake","year":"2010","unstructured":"Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, Coenen MJ, Vonk MC, Voskuyl AE, Schuerwegh AJ, Broen JC, van Riel PL, van\u2019t Slot R, Italiaander A, Ophoff RA, Riemekasten G, Hunzelmann N, Simeon CP, Ortego-Centeno N, Gonzalez-Gay MA, Gonzalez-Escribano MF, Spanish Scleroderma G, Airo P, van Laar J, Herrick A, Worthington J, Hesselstrand R, Smith V, de Keyser F, Houssiau F, Chee MM, Madhok R, Shiels P, Westhovens R, Kreuter A, Kiener H, de Baere E, Witte T, Padykov L, Klareskog L, Beretta L, Scorza R, Lie BA, Hoffmann-Vold AM, Carreira P, Varga J, Hinchcliff M, Gregersen PK, Lee AT, Ying J, Han Y, Weng SF, Amos CI, Wigley FM, Hummers L, Nelson JL, Agarwal SK, Assassi S, Gourh P, Tan FK, Koeleman BP, Arnett FC, Martin J, Mayes MD (2010) Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 42(5):426\u2013429. doi:\n                    10.1038\/ng.565","journal-title":"Nat Genet"},{"issue":"1","key":"8636_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","volume":"94","author":"MD Mayes","year":"2014","unstructured":"Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV, Assassi S, Ying J, Tan FK, Arnett FC, Reveille JD, Guerra S, Teruel M, Carmona FD, Gregersen PK, Lee AT, Lopez-Isac E, Ochoa E, Carreira P, Simeon CP, Castellvi I, Gonzalez-Gay MA, Spanish Scleroderma G, Zhernakova A, Padyukov L, Alarcon-Riquelme M, Wijmenga C, Brown M, Beretta L, Riemekasten G, Witte T, Hunzelmann N, Kreuter A, Distler JH, Voskuyl AE, Schuerwegh AJ, Hesselstrand R, Nordin A, Airo P, Lunardi C, Shiels P, van Laar JM, Herrick A, Worthington J, Denton C, Wigley FM, Hummers LK, Varga J, Hinchcliff ME, Baron M, Hudson M, Pope JE, Furst DE, Khanna D, Phillips K, Schiopu E, Segal BM, Molitor JA, Silver RM, Steen VD, Simms RW, Lafyatis RA, Fessler BJ, Frech TM, Alkassab F, Docherty P, Kaminska E, Khalidi N, Jones HN, Markland J, Robinson D, Broen J, Radstake TR, Fonseca C, Koeleman BP, Martin J (2014) Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet 94(1):47\u201361. doi:\n                    10.1016\/j.ajhg.2013.12.002","journal-title":"Am J Hum Genet"},{"issue":"12","key":"8636_CR33","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1136\/annrheumdis-2015-208029","volume":"75","author":"N Ruzehaji","year":"2016","unstructured":"Ruzehaji N, Frantz C, Ponsoye M, Avouac J, Pezet S, Guilbert T, Luccarini JM, Broqua P, Junien JL, Allanore Y (2016) Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis. Ann Rheum Dis 75(12):2175\u20132183. doi:\n                    10.1136\/annrheumdis-2015-208029","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8636_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bjd.12913","volume":"171","author":"YY Wang","year":"2014","unstructured":"Wang YY, Wang Q, Sun XH, Liu RZ, Shu Y, Kanekura T, Huang JH, Li YP, Wang JC, Zhao M, Lu QJ, Xiao R (2014) DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis. Br J Dermatol 171(1):39\u201347. doi:\n                    10.1111\/bjd.12913","journal-title":"Br J Dermatol"},{"issue":"6","key":"8636_CR35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1164\/rccm.201408-1464OC","volume":"191","author":"AJ Gilbane","year":"2015","unstructured":"Gilbane AJ, Derrett-Smith E, Trinder SL, Good RB, Pearce A, Denton CP, Holmes AM (2015) Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-beta-dependent mouse model of pulmonary hypertension and in systemic sclerosis. Am J Respir Crit Care Med 191(6):665\u2013677. doi:\n                    10.1164\/rccm.201408-1464OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"8636_CR36","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/jcmm.12105","volume":"17","author":"Y Wang","year":"2013","unstructured":"Wang Y, Kahaleh B (2013) Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma. J Cell Mol Med 17(10):1291\u20131299. doi:\n                    10.1111\/jcmm.12105","journal-title":"J Cell Mol Med"},{"issue":"9","key":"8636_CR37","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/art.40163","volume":"69","author":"Marzia Rossato","year":"2017","unstructured":"Rossato M, Affandi AJ, Thordardottir S, Wichers CGK, Cossu M, Broen JCA, Moret FM, Bossini-Castillo L, Chouri E, van Bon L, Wolters F, Marut W, van der Kroef M, Silva-Cardoso S, Bekker CPJ, Dolstra H, van Laar JM, Martin J, van Roon JAG, Reedquist KA, Beretta L, Radstake T (2017) Expression of miR-618 in plasmacytoid dendritic cells from systemic sclerosis patients is associated with their altered frequency and activation. Arthritis Rheumatol. doi:\n                    10.1002\/art.40163","journal-title":"Arthritis & Rheumatology"},{"issue":"8","key":"8636_CR38","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","volume":"75","author":"Z Brkic","year":"2016","unstructured":"Brkic Z, van Bon L, Cossu M, van Helden-Meeuwsen CG, Vonk MC, Knaapen H, van den Berg W, Dalm VA, Van Daele PL, Severino A, Maria NI, Guillen S, Dik WA, Beretta L, Versnel MA, Radstake T (2016) The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Ann Rheum Dis 75(8):1567\u20131573. doi:\n                    10.1136\/annrheumdis-2015-207392","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"8636_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0049-0172(75)90017-7","volume":"4","author":"PM Campbell","year":"1975","unstructured":"Campbell PM, LeRoy EC (1975) Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 4(4):351\u2013368","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"8636_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/path.1711660307","volume":"166","author":"RJ Prescott","year":"1992","unstructured":"Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P (1992) Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166(3):255\u2013263. doi:\n                    10.1002\/path.1711660307","journal-title":"J Pathol"},{"issue":"5","key":"8636_CR41","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/1529-0131(200005)43:5<1085::AID-ANR19>3.0.CO;2-7","volume":"43","author":"GN Andersen","year":"2000","unstructured":"Andersen GN, Caidahl K, Kazzam E, Petersson AS, Waldenstrom A, Mincheva-Nilsson L, Rantapaa-Dahlqvist S (2000) Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1. Arthritis Rheum 43(5):1085\u20131093. doi:\n                    10.1002\/1529-0131(200005)43:5<1085::AID-ANR19>3.0.CO;2-7","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8636_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/art.1780380206","volume":"38","author":"MS Gruschwitz","year":"1995","unstructured":"Gruschwitz MS, Hornstein OP, von Den Driesch P (1995) Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 38(2):184\u2013189","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8636_CR43","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/rheumatology\/kep091","volume":"48","author":"BJ Rabquer","year":"2009","unstructured":"Rabquer BJ, Hou Y, Del Galdo F, Kenneth Haines G 3rd, Gerber ML, Jimenez SA, Seibold JR, Koch AE (2009) The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatology (Oxford) 48(7):734\u2013740. doi:\n                    10.1093\/rheumatology\/kep091","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"8636_CR44","first-page":"1838","volume":"21","author":"R Vancheeswaran","year":"1994","unstructured":"Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, Black CM (1994) Circulating endothelin-1 levels in systemic sclerosis subsets\u2014a marker of fibrosis or vascular dysfunction? J Rheumatol 21(10):1838\u20131844","journal-title":"J Rheumatol"},{"issue":"2","key":"8636_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.0.CO;2-4","volume":"189","author":"SA Cotton","year":"1999","unstructured":"Cotton SA, Herrick AL, Jayson MI, Freemont AJ (1999) Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin. J Pathol 189(2):273\u2013278. doi:\n                    10.1002\/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.0.CO;2-4","journal-title":"J Pathol"},{"issue":"11","key":"8636_CR46","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","volume":"44","author":"P Sambo","year":"2001","unstructured":"Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, Gabrielli A (2001) Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 44(11):2653\u20132664","journal-title":"Arthritis Rheum"},{"issue":"6","key":"8636_CR47","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/ar596","volume":"4","author":"O Distler","year":"2002","unstructured":"Distler O, Del Rosso A, Giacomelli R, Cipriani P, Conforti ML, Guiducci S, Gay RE, Michel BA, Bruhlmann P, Muller-Ladner U, Gay S, Matucci-Cerinic M (2002) Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Arthritis Res 4(6):R11. doi:\n                    10.1186\/ar596","journal-title":"Arthritis Res"},{"issue":"1","key":"8636_CR48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","volume":"95","author":"O Distler","year":"2004","unstructured":"Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, Michel BA, Gay RE, Muller-Ladner U, Matucci-Cerinic M, Plate KH, Gassmann M, Gay S (2004) Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 95(1):109\u2013116. doi:\n                    10.1161\/01.RES.0000134644.89917.96","journal-title":"Circ Res"},{"issue":"11","key":"8636_CR49","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1002\/art.23968","volume":"58","author":"J Avouac","year":"2008","unstructured":"Avouac J, Wipff J, Goldman O, Ruiz B, Couraud PO, Chiocchia G, Kahan A, Boileau C, Uzan G, Allanore Y (2008) Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Arthritis Rheum 58(11):3550\u20133561. doi:\n                    10.1002\/art.23968","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8636_CR50","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","volume":"109","author":"M Manetti","year":"2011","unstructured":"Manetti M, Guiducci S, Romano E, Ceccarelli C, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M (2011) Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Circ Res 109(3):e14\u2013e26. doi:\n                    10.1161\/CIRCRESAHA.111.242057","journal-title":"Circ Res"},{"issue":"8","key":"8636_CR51","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/art.22035","volume":"54","author":"N Papa Del","year":"2006","unstructured":"Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, Maglione W, Comina DP, Vitali C, Fraticelli P, Gabrielli A, Cortelezzi A, Lambertenghi-Deliliers G (2006) Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 54(8):2605\u20132615. doi:\n                    10.1002\/art.22035","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8636_CR52","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28(7):1573\u20131576","journal-title":"J Rheumatol"},{"issue":"3","key":"8636_CR53","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/ar4236","volume":"15","author":"G Valentini","year":"2013","unstructured":"Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, Santoriello C, Ciani A, Cozzolino D, De Matteis GM, Cappabianca S, Vitelli F, Spano A (2013) Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers. Arthritis Res Ther 15(3):R63. doi:\n                    10.1186\/ar4236","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"8636_CR54","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senecal JL (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 58(12):3902\u20133912. doi:\n                    10.1002\/art.24038","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8636_CR55","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/rheumatology\/keu381","volume":"54","author":"B Vigone","year":"2015","unstructured":"Vigone B, Santaniello A, Marchini M, Montanelli G, Caronni M, Severino A, Beretta L (2015) Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis. Rheumatology (Oxford) 54(4):707\u2013711. doi:\n                    10.1093\/rheumatology\/keu381","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"8636_CR56","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Muller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative. Ann Rheum Dis 72(11):1747\u20131755. doi:\n                    10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"8636_CR57","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","volume":"34","author":"S Vettori","year":"2014","unstructured":"Vettori S, Cuomo G, Iudici M, D\u2019Abrosca V, Giacco V, Barra G, De Palma R, Valentini G (2014) Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels. J Clin Immunol 34(6):663\u2013668. doi:\n                    10.1007\/s10875-014-0037-0","journal-title":"J Clin Immunol"},{"issue":"6","key":"8636_CR58","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/rheumatology\/kew017","volume":"55","author":"M Cossu","year":"2016","unstructured":"Cossu M, Andracco R, Santaniello A, Marchini M, Severino A, Caronni M, Radstake T, Beretta L (2016) Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients. Rheumatology (Oxford) 55(6):1112\u20131116. doi:\n                    10.1093\/rheumatology\/kew017","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8636_CR59","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI118851","volume":"98","author":"R Sgonc","year":"1996","unstructured":"Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G (1996) Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 98(3):785\u2013792. doi:\n                    10.1172\/JCI118851","journal-title":"J Clin Invest"},{"issue":"7","key":"8636_CR60","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.4049\/jimmunol.168.7.3649","volume":"168","author":"LI Sakkas","year":"2002","unstructured":"Sakkas LI, Xu B, Artlett CM, Lu S, Jimenez SA, Platsoucas CD (2002) Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 168(7):3649\u20133659","journal-title":"J Immunol"},{"issue":"6","key":"8636_CR61","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/art.1780270607","volume":"27","author":"AD Roumm","year":"1984","unstructured":"Roumm AD, Whiteside TL, Medsger TA Jr, Rodnan GP (1984) Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 27(6):645\u2013653","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8636_CR62","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/art.37706","volume":"65","author":"P Fuschiotti","year":"2013","unstructured":"Fuschiotti P, Larregina AT, Ho J, Feghali-Bostwick C, Medsger TA Jr (2013) Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum 65(1):236\u2013246. doi:\n                    10.1002\/art.37706","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8636_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000163933","volume":"63","author":"BM Kraling","year":"1995","unstructured":"Kraling BM, Maul GG, Jimenez SA (1995) Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes\/macrophages. Pathobiology 63(1):48\u201356","journal-title":"Pathobiology"},{"issue":"8","key":"8636_CR64","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1136\/ard.2004.027094","volume":"64","author":"A Kalogerou","year":"2005","unstructured":"Kalogerou A, Gelou E, Mountantonakis S, Settas L, Zafiriou E, Sakkas L (2005) Early T cell activation in the skin from patients with systemic sclerosis. Ann Rheum Dis 64(8):1233\u20131235. doi:\n                    10.1136\/ard.2004.027094","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8636_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S","volume":"41","author":"R Giacomelli","year":"1998","unstructured":"Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G (1998) Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 41(2):327\u2013334. doi:\n                    10.1002\/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8636_CR66","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/ard.2009.116525","volume":"70","author":"S Klein","year":"2011","unstructured":"Klein S, Kretz CC, Ruland V, Stumpf C, Haust M, Hartschuh W, Hartmann M, Enk A, Suri-Payer E, Oberle N, Krammer PH, Kuhn A (2011) Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma. Ann Rheum Dis 70(8):1475\u20131481. doi:\n                    10.1136\/ard.2009.116525","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8636_CR67","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","volume":"43","author":"R Sgonc","year":"2000","unstructured":"Sgonc R, Gruschwitz MS, Boeck G, Sepp N, Gruber J, Wick G (2000) Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 43(11):2550\u20132562. doi:\n                    10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8636_CR68","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00007890-199807150-00011","volume":"66","author":"WJ Waldman","year":"1998","unstructured":"Waldman WJ, Knight DA, Adams PW (1998) Cytolytic activity against allogeneic human endothelia: resistance of cytomegalovirus-infected cells and virally activated lysis of uninfected cells. Transplantation 66(1):67\u201377","journal-title":"Transplantation"},{"issue":"3","key":"8636_CR69","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/art.22382","volume":"56","author":"MR York","year":"2007","unstructured":"York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R (2007) A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum 56(3):1010\u20131020. doi:\n                    10.1002\/art.22382","journal-title":"Arthritis Rheum"},{"issue":"11","key":"8636_CR70","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/ard.2011.150326","volume":"70","author":"BW Higgs","year":"2011","unstructured":"Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y (2011) Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 70(11):2029\u20132036. doi:\n                    10.1136\/ard.2011.150326","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"8636_CR71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L Bon van","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mathes AL, Cossu M, York M, Collins C, Wenink M, Huijbens R, Hesselstrand R, Saxne T, DiMarzio M, Wuttge D, Agarwal SK, Reveille JD, Assassi S, Mayes M, Deng Y, Drenth JP, de Graaf J, den Heijer M, Kallenberg CG, Bijl M, Loof A, van den Berg WB, Joosten LA, Smith V, de Keyser F, Scorza R, Lunardi C, van Riel PL, Vonk M, van Heerde W, Meller S, Homey B, Beretta L, Roest M, Trojanowska M, Lafyatis R, Radstake TR (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med 370(5):433\u2013443. doi:\n                    10.1056\/NEJMoa1114576","journal-title":"N Engl J Med"},{"issue":"6","key":"8636_CR72","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/BOR.0b013e32834b0dac","volume":"23","author":"L Bon van","year":"2011","unstructured":"van Bon L, Cossu M, Radstake TR (2011) An update on an immune system that goes awry in systemic sclerosis. Curr Opin Rheumatol 23(6):505\u2013510. doi:\n                    10.1097\/BOR.0b013e32834b0dac","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"8636_CR73","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1136\/ard.2009.128207","volume":"69","author":"L Bon van","year":"2010","unstructured":"van Bon L, Popa C, Huijbens R, Vonk M, York M, Simms R, Hesselstrand R, Wuttge DM, Lafyatis R, Radstake TR (2010) Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 69(8):1539\u20131547. doi:\n                    10.1136\/ard.2009.128207","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8636_CR74","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/art.21278","volume":"52","author":"MF Roelofs","year":"2005","unstructured":"Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, van Lieshout AW, Sprong T, van den Hoogen FH, van den Berg WB, Radstake TR (2005) The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7\/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 52(8):2313\u20132322. doi:\n                    10.1002\/art.21278","journal-title":"Arthritis Rheum"},{"issue":"11","key":"8636_CR75","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri1957","volume":"6","author":"A Marshak-Rothstein","year":"2006","unstructured":"Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6(11):823\u2013835. doi:\n                    10.1038\/nri1957","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"8636_CR76","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","volume":"43","author":"K Kurasawa","year":"2000","unstructured":"Kurasawa K, Hirose K, Sano H, Endo H, Shinkai H, Nawata Y, Takabayashi K, Iwamoto I (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43(11):2455\u20132463. doi:\n                    10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8636_CR77","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/art.37860","volume":"65","author":"ME Truchetet","year":"2013","unstructured":"Truchetet ME, Brembilla NC, Montanari E, Lonati P, Raschi E, Zeni S, Fontao L, Meroni PL, Chizzolini C (2013) Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement. Arthritis Rheum 65(5):1347\u20131356. doi:\n                    10.1002\/art.37860","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8636_CR78","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1186\/ar4334","volume":"15","author":"NC Brembilla","year":"2013","unstructured":"Brembilla NC, Montanari E, Truchetet ME, Raschi E, Meroni P, Chizzolini C (2013) Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts. Arthritis Res Ther 15(5):R151. doi:\n                    10.1186\/ar4334","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"8636_CR79","first-page":"1751","volume":"151","author":"C Mavalia","year":"1997","unstructured":"Mavalia C, Scaletti C, Romagnani P, Carossino AM, Pignone A, Emmi L, Pupilli C, Pizzolo G, Maggi E, Romagnani S (1997) Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 151(6):1751\u20131758","journal-title":"Am J Pathol"},{"issue":"10","key":"8636_CR80","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1002\/art.22927","volume":"56","author":"Y Parel","year":"2007","unstructured":"Parel Y, Aurrand-Lions M, Scheja A, Dayer JM, Roosnek E, Chizzolini C (2007) Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum 56(10):3459\u20133467. doi:\n                    10.1002\/art.22927","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8636_CR81","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.4049\/jimmunol.171.7.3655","volume":"171","author":"NG Sandler","year":"2003","unstructured":"Sandler NG, Mentink-Kane MM, Cheever AW, Wynn TA (2003) Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol 171(7):3655\u20133667","journal-title":"J Immunol"},{"issue":"3","key":"8636_CR82","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1023\/A:1011024313525","volume":"21","author":"G Valentini","year":"2001","unstructured":"Valentini G, Baroni A, Esposito K, Naclerio C, Buommino E, Farzati A, Cuomo G, Farzati B (2001) Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J Clin Immunol 21(3):210\u2013217","journal-title":"J Clin Immunol"},{"issue":"6","key":"8636_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005981","volume":"4","author":"TR Radstake","year":"2009","unstructured":"Radstake TR, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, Hussaini A, Simms R, Cruikshank WW, Lafyatis R (2009) Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS One 4(6):e5981. doi:\n                    10.1371\/journal.pone.0005981","journal-title":"PLoS One"},{"issue":"4","key":"8636_CR84","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.0022-202X.2005.23767.x","volume":"125","author":"M Horikawa","year":"2005","unstructured":"Horikawa M, Hasegawa M, Komura K, Hayakawa I, Yanaba K, Matsushita T, Takehara K, Sato S (2005) Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity. J Invest Dermatol 125(4):731\u2013737. doi:\n                    10.1111\/j.0022-202X.2005.23767.x","journal-title":"J Invest Dermatol"},{"key":"8636_CR85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clim.2016.09.004","volume":"173","author":"M Cossu","year":"2016","unstructured":"Cossu M, van Bon L, Nierkens S, Bellocchi C, Santaniello A, Dolstra H, Beretta L, Radstake TR (2016) The magnitude of cytokine production by stimulated CD56+ cells is associated with early stages of systemic sclerosis. Clin Immunol 173:76\u201380. doi:\n                    10.1016\/j.clim.2016.09.004","journal-title":"Clin Immunol"},{"issue":"3","key":"8636_CR86","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12016-015-8505-8","volume":"49","author":"I Almeida","year":"2015","unstructured":"Almeida I, Silva SV, Fonseca AR, Silva I, Vasconcelos C, Lima M (2015) T and NK cell phenotypic abnormalities in systemic sclerosis: a cohort study and a comprehensive literature review. Clin Rev Allergy Immunol 49(3):347\u2013369. doi:\n                    10.1007\/s12016-015-8505-8","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"8636_CR87","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/art.11179","volume":"48","author":"M Worda","year":"2003","unstructured":"Worda M, Sgonc R, Dietrich H, Niederegger H, Sundick RS, Gershwin ME, Wick G (2003) In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum 48(9):2605\u20132614. doi:\n                    10.1002\/art.11179","journal-title":"Arthritis Rheum"},{"issue":"7","key":"8636_CR88","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/art.23486","volume":"58","author":"D Kim","year":"2008","unstructured":"Kim D, Peck A, Santer D, Patole P, Schwartz SM, Molitor JA, Arnett FC, Elkon KB (2008) Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis. Arthritis Rheum 58(7):2163\u20132173. doi:\n                    10.1002\/art.23486","journal-title":"Arthritis Rheum"},{"issue":"6335","key":"8636_CR89","doi-asserted-by":"publisher","first-page":"eaah4573","DOI":"10.1126\/science.aah4573","volume":"356","author":"Alexandra-Chlo\u00e9 Villani","year":"2017","unstructured":"Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, Griesbeck M, Butler A, Zheng S, Lazo S, Jardine L, Dixon D, Stephenson E, Nilsson E, Grundberg I, McDonald D, Filby A, Li W, De Jager PL, Rozenblatt-Rosen O, Lane AA, Haniffa M, Regev A, Hacohen N (2017) Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356(6335). doi:\n                    10.1126\/science.aah4573","journal-title":"Science"},{"issue":"5","key":"8636_CR90","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni.3693","volume":"18","author":"JC Rieckmann","year":"2017","unstructured":"Rieckmann JC, Geiger R, Hornburg D, Wolf T, Kveler K, Jarrossay D, Sallusto F, Shen-Orr SS, Lanzavecchia A, Mann M, Meissner F (2017) Social network architecture of human immune cells unveiled by quantitative proteomics. Nat Immunol 18(5):583\u2013593. doi:\n                    10.1038\/ni.3693","journal-title":"Nat Immunol"},{"issue":"6269","key":"8636_CR91","doi-asserted-by":"publisher","first-page":"aab2116","DOI":"10.1126\/science.aab2116","volume":"351","author":"F Notta","year":"2016","unstructured":"Notta F, Zandi S, Takayama N, Dobson S, Gan OI, Wilson G, Kaufmann KB, McLeod J, Laurenti E, Dunant CF, McPherson JD, Stein LD, Dror Y, Dick JE (2016) Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science 351(6269):aab2116. doi:\n                    10.1126\/science.aab2116","journal-title":"Science"},{"issue":"5","key":"8636_CR92","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.cell.2016.09.037","volume":"167","author":"BM Javierre","year":"2016","unstructured":"Javierre BM, Burren OS, Wilder SP, Kreuzhuber R, Hill SM, Sewitz S, Cairns J, Wingett SW, Varnai C, Thiecke MJ, Burden F, Farrow S, Cutler AJ, Rehnstrom K, Downes K, Grassi L, Kostadima M, Freire-Pritchett P, Wang F, Consortium B, Stunnenberg HG, Todd JA, Zerbino DR, Stegle O, Ouwehand WH, Frontini M, Wallace C, Spivakov M, Fraser P (2016) Lineage-specific genome architecture links enhancers and non-coding disease variants to target gene promoters. Cell 167(5):1369\u20131384 e1319. doi:\n                    10.1016\/j.cell.2016.09.037","journal-title":"Cell"},{"issue":"10","key":"8636_CR93","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/ard.50.10.666","volume":"50","author":"CG Kallenberg","year":"1991","unstructured":"Kallenberg CG (1991) Connective tissue disease in patients presenting with Raynaud\u2019s phenomenon alone. Ann Rheum Dis 50(10):666\u2013667","journal-title":"Ann Rheum Dis"},{"key":"8636_CR94","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","volume":"48-49","author":"E Maverakis","year":"2014","unstructured":"Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y, Guiducci S, Hesselstrand R, Hummers LK, Duong C, Kahaleh B, Macgregor A, Matucci-Cerinic M, Wollheim FA, Mayes MD, Gershwin ME (2014) International consensus criteria for the diagnosis of Raynaud\u2019s phenomenon. J Autoimmun 48-49:60\u201365. doi:\n                    10.1016\/j.jaut.2014.01.020","journal-title":"J Autoimmun"},{"issue":"9","key":"8636_CR95","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/art.27543","volume":"62","author":"AL Herrick","year":"2010","unstructured":"Herrick AL, Cutolo M (2010) Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 62(9):2595\u20132604. doi:\n                    10.1002\/art.27543","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8636_CR96","first-page":"155","volume":"27","author":"M Cutolo","year":"2000","unstructured":"Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27(1):155\u2013160","journal-title":"J Rheumatol"},{"issue":"7","key":"8636_CR97","first-page":"1471","volume":"28","author":"FM Wigley","year":"2001","unstructured":"Wigley FM (2001) When is scleroderma really scleroderma? J Rheumatol 28(7):1471\u20131473","journal-title":"J Rheumatol"},{"issue":"4","key":"8636_CR98","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/rheumatology\/kep447","volume":"49","author":"F Ingegnoli","year":"2010","unstructured":"Ingegnoli F, Boracchi P, Gualtierotti R, Biganzoli EM, Zeni S, Lubatti C, Fantini F (2010) Improving outcome prediction of systemic sclerosis from isolated Raynaud\u2019s phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatology (Oxford) 49(4):797\u2013805. doi:\n                    10.1093\/rheumatology\/kep447","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"8636_CR99","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/acr.22304","volume":"66","author":"G Valentini","year":"2014","unstructured":"Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, Santoriello C, Ciani A, Cozzolino D, De Matteis GM, Cappabianca S, Vitelli F, Spano A (2014) Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and\/or capillaroscopic positivity. Arthritis Care Res 66(10):1520\u20131527. doi:\n                    10.1002\/acr.22304","journal-title":"Arthritis Care Res"},{"issue":"5","key":"8636_CR100","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Alfonse T. Masi","year":"1980","unstructured":"Masi TA (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581\u2013590","journal-title":"Arthritis & Rheumatism"},{"issue":"2","key":"8636_CR101","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/ar628","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5(2):80\u201393","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8636_CR102","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F","volume":"44","author":"LS Lonzetti","year":"2001","unstructured":"Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Senecal JL (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735\u2013736. doi:\n                    10.1002\/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F","journal-title":"Arthritis Rheum"},{"issue":"8","key":"8636_CR103","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/rheumatology\/keu530","volume":"54","author":"S Jordan","year":"2015","unstructured":"Jordan S, Maurer B, Toniolo M, Michel B, Distler O (2015) Performance of the new ACR\/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology (Oxford) 54(8):1454\u20131458. doi:\n                    10.1093\/rheumatology\/keu530","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"8636_CR104","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/acr.22451","volume":"67","author":"H Alhajeri","year":"2015","unstructured":"Alhajeri H, Hudson M, Fritzler M, Pope J, Tatibouet S, Markland J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larche M, Baron M (2015) 2013 American College of Rheumatology\/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. Arthritis Care Res 67(4):582\u2013587. doi:\n                    10.1002\/acr.22451","journal-title":"Arthritis Care Res"},{"issue":"11","key":"8636_CR105","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","volume":"43","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43(11):2437\u20132444. doi:\n                    10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","journal-title":"Arthritis Rheum"},{"issue":"2 Suppl 58","key":"8636_CR106","first-page":"S18","volume":"28","author":"L Beretta","year":"2010","unstructured":"Beretta L, Santaniello A, Cappiello F, Chawla NV, Vonk MC, Carreira PE, Allanore Y, Popa-Diaconu DA, Cossu M, Bertolotti F, Ferraccioli G, Mazzone A, Scorza R (2010) Development of a five-year mortality model in systemic sclerosis patients by different analytical approaches. Clin Exp Rheumatol 28(2 Suppl 58):S18\u2013S27","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"8636_CR107","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2010.104","volume":"6","author":"M Cutolo","year":"2010","unstructured":"Cutolo M, Sulli A, Smith V (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat Rev Rheumatol 6(10):578\u2013587. doi:\n                    10.1038\/nrrheum.2010.104","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"8636_CR108","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/art.33463","volume":"64","author":"A Sulli","year":"2012","unstructured":"Sulli A, Pizzorni C, Smith V, Zampogna G, Ravera F, Cutolo M (2012) Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum 64(3):821\u2013825. doi:\n                    10.1002\/art.33463","journal-title":"Arthritis Rheum"},{"issue":"10","key":"8636_CR109","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/rheumatology\/kem190","volume":"46","author":"P Caramaschi","year":"2007","unstructured":"Caramaschi P, Canestrini S, Martinelli N, Volpe A, Pieropan S, Ferrari M, Bambara LM, Carletto A, Biasi D (2007) Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) 46(10):1566\u20131569. doi:\n                    10.1093\/rheumatology\/kem190","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8636_CR110","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3899\/jrheum.130528","volume":"40","author":"V Smith","year":"2013","unstructured":"Smith V, Riccieri V, Pizzorni C, Decuman S, Deschepper E, Bonroy C, Sulli A, Piette Y, De Keyser F, Cutolo M (2013) Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol 40(12):2023\u20132028. doi:\n                    10.3899\/jrheum.130528","journal-title":"J Rheumatol"},{"issue":"8","key":"8636_CR111","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.autrev.2017.05.019","volume":"16","author":"Stergios Soulaidopoulos","year":"2017","unstructured":"Soulaidopoulos S, Triantafyllidou E, Garyfallos A, Kitas GD, Dimitroulas T (2017) The role of nailfold capillaroscopy in the assessment of internal organ involvement in systemic sclerosis: a critical review. Autoimmun Rev. doi:\n                    10.1016\/j.autrev.2017.05.019","journal-title":"Autoimmunity Reviews"},{"issue":"10","key":"8636_CR112","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","volume":"71","author":"V Smith","year":"2012","unstructured":"Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M (2012) Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis 71(10):1636\u20131639. doi:\n                    10.1136\/annrheumdis-2011-200780","journal-title":"Ann Rheum Dis"},{"issue":"3 Suppl 29","key":"8636_CR113","first-page":"S42","volume":"21","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(3 Suppl 29):S42\u2013S46","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"8636_CR114","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/ard.2010.132431","volume":"70","author":"V Smith","year":"2011","unstructured":"Smith V, De Keyser F, Pizzorni C, Van Praet JT, Decuman S, Sulli A, Deschepper E, Cutolo M (2011) Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis 70(1):180\u2013183. doi:\n                    10.1136\/ard.2010.132431","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"8636_CR115","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/art.39718","volume":"68","author":"M Cutolo","year":"2016","unstructured":"Cutolo M, Herrick AL, Distler O, Becker MO, Beltran E, Carpentier P, Ferri C, Inanc M, Vlachoyiannopoulos P, Chadha-Boreham H, Cottreel E, Pfister T, Rosenberg D, Torres JV, Smith V, Investigators CAPS (2016) Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study. Arthritis Rheumatol 68(10):2527\u20132539. doi:\n                    10.1002\/art.39718","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"8636_CR116","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"issue":"6","key":"8636_CR117","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66(6):754\u2013763. doi:\n                    10.1136\/ard.2006.062901","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8636_CR118","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/acr.21716","volume":"64","author":"C Muangchan","year":"2012","unstructured":"Muangchan C, Harding S, Khimdas S, Bonner A, Canadian Scleroderma Research G, Baron M, Pope J (2012) Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group. Arthritis Care Res 64(9):1405\u20131414. doi:\n                    10.1002\/acr.21716","journal-title":"Arthritis Care Res"},{"issue":"2","key":"8636_CR119","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","volume":"29","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger TA Jr (2003) Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin N Am 29(2):255\u2013273 vi","journal-title":"Rheum Dis Clin N Am"},{"issue":"11","key":"8636_CR120","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/rheumatology\/kew305","volume":"55","author":"WM Hombergh van den","year":"2016","unstructured":"van den Hombergh WM, Carreira PE, Knaapen-Hans HK, van den Hoogen FH, Fransen J, Vonk MC (2016) An easy prediction rule for diffuse cutaneous systemic sclerosis using only the timing and type of first symptoms and auto-antibodies: derivation and validation. Rheumatology (Oxford) 55(11):2023\u20132032. doi:\n                    10.1093\/rheumatology\/kew305","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"8636_CR121","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/art.39490","volume":"68","author":"RT Domsic","year":"2016","unstructured":"Domsic RT, Nihtyanova SI, Wisniewski SR, Fine MJ, Lucas M, Kwoh CK, Denton CP, Medsger TA Jr (2016) Derivation and external validation of a prediction rule for five-year mortality in patients with early diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 68(4):993\u20131003. doi:\n                    10.1002\/art.39490","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"8636_CR122","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/art.38381","volume":"66","author":"RT Domsic","year":"2014","unstructured":"Domsic RT, Nihtyanova SI, Wisniewski SR, Fine MJ, Lucas M, Kwoh CK, Denton CP, Medsger TA Jr (2014) Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 66(6):1616\u20131624. doi:\n                    10.1002\/art.38381","journal-title":"Arthritis Rheumatol"},{"issue":"suppl_1","key":"8636_CR123","doi-asserted-by":"publisher","first-page":"i78","DOI":"10.1093\/rheumatology\/kew339","volume":"56","author":"M Teruel","year":"2017","unstructured":"Teruel M, Chamberlain C, Alarcon-Riquelme ME (2017) Omics studies: their use in diagnosis and reclassification of SLE and other systemic autoimmune diseases. Rheumatology (Oxford) 56(suppl_1):i78\u2013i87. doi:\n                    10.1093\/rheumatology\/kew339","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"8636_CR124","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/art.38101","volume":"65","author":"S Assassi","year":"2013","unstructured":"Assassi S, Wu M, Tan FK, Chang J, Graham TA, Furst DE, Khanna D, Charles J, Ferguson EC, Feghali-Bostwick C, Mayes MD (2013) Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis. Arthritis Rheum 65(11):2917\u20132927. doi:\n                    10.1002\/art.38101","journal-title":"Arthritis Rheum"},{"issue":"21","key":"8636_CR125","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89073","volume":"1","author":"S Lofgren","year":"2016","unstructured":"Lofgren S, Hinchcliff M, Carns M, Wood T, Aren K, Arroyo E, Cheung P, Kuo A, Valenzuela A, Haemel A, Wolters PJ, Gordon J, Spiera R, Assassi S, Boin F, Chung L, Fiorentino D, Utz PJ, Whitfield ML, Khatri P (2016) Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severity. JCI Insight 1(21):e89073. doi:\n                    10.1172\/jci.insight.89073","journal-title":"JCI Insight"},{"issue":"5","key":"8636_CR126","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3899\/jrheum.160833","volume":"44","author":"DJ Haddon","year":"2017","unstructured":"Haddon DJ, Wand HE, Jarrell JA, Spiera RF, Utz PJ, Gordon JK, Chung LS (2017) Proteomic analysis of sera from individuals with diffuse cutaneous systemic sclerosis reveals a multianalyte signature associated with clinical improvement during imatinib mesylate treatment. J Rheumatol 44(5):631\u2013638. doi:\n                    10.3899\/jrheum.160833","journal-title":"J Rheumatol"},{"issue":"1","key":"8636_CR127","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13075-016-1203-y","volume":"18","author":"ER Volkmann","year":"2016","unstructured":"Volkmann ER, Tashkin DP, Roth MD, Clements PJ, Khanna D, Furst DE, Mayes M, Charles J, Tseng CH, Elashoff RM, Assassi S (2016) Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease. Arthritis Res Ther 18(1):305. doi:\n                    10.1186\/s13075-016-1203-y","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8636_CR128","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2016-209768","volume":"76","author":"G Valentini","year":"2017","unstructured":"Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirjak L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Muller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76(1):270\u2013276. doi:\n                    10.1136\/annrheumdis-2016-209768","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"8636_CR129","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/art.39501","volume":"68","author":"D Khanna","year":"2016","unstructured":"Khanna D, Berrocal VJ, Giannini EH, Seibold JR, Merkel PA, Mayes MD, Baron M, Clements PJ, Steen V, Assassi S, Schiopu E, Phillips K, Simms RW, Allanore Y, Denton CP, Distler O, Johnson SR, Matucci-Cerinic M, Pope JE, Proudman SM, Siegel J, Wong WK, Wells AU, Furst DE (2016) The American College of Rheumatology provisional composite response index for clinical trials in early diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 68(2):299\u2013311. doi:\n                    10.1002\/art.39501","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"8636_CR130","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/acr.22807","volume":"68","author":"KE Riehm","year":"2016","unstructured":"Riehm KE, Kwakkenbos L, Carrier ME, Bartlett SJ, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Nielsen K, Baron M, Frech T, Hudson M, Pope J, Sauve M, Suarez-Almazor ME, Wigley FM, Thombs BD, Scleroderma Patient-Centered Intervention Network I (2016) Validation of the self-efficacy for managing chronic disease scale: a scleroderma patient-centered intervention network cohort study. Arthritis Care Res 68(8):1195\u20131200. doi:\n                    10.1002\/acr.22807","journal-title":"Arthritis Care Res"},{"key":"8636_CR131","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/ard.2008.095299","volume":"68","author":"J Avouac","year":"2009","unstructured":"Avouac J, Kowal-Bielecka O, Landewe R, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, F\u00f6ldvari I, Furst DE, M\u00fcller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M, EUSTAR Coauthors (2009) European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Ann Rheum Dis 68:629\u2013634","journal-title":"Ann Rheum Dis"},{"key":"8636_CR132","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, JHW D, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, M\u00fcller-Ladner U, EUSTAR Coauthors (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76:1327\u20131339","journal-title":"Ann Rheum Dis"},{"key":"8636_CR133","first-page":"S3","volume":"33","author":"CP Denton","year":"2015","unstructured":"Denton CP (2015) Systemic sclerosis: from pathogenesis to targeted therapy. Clin Exp Rheumatol 33:S3\u2013S7","journal-title":"Clin Exp Rheumatol"},{"key":"8636_CR134","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/ard.2005.050187","volume":"65","author":"D Khanna","year":"2006","unstructured":"Khanna D, Furst DE, Hays RD, Park GS, Wong WK, Seibold JR, Mayes MD, White B, Wigley FF, Weisman M, Barr W, Moreland L, Medsger TA Jr, Steen VD, Martin RW, Collier D, Weinstein A, Lally EV, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ (2006) Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis 65:1325\u20131329","journal-title":"Ann Rheum Dis"},{"key":"8636_CR135","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s11136-007-9207-3","volume":"16","author":"D Khanna","year":"2007","unstructured":"Khanna D, Furst DE, Wong WK, Tsevat J, Clements PJ, Park GS, Postlethwaite AE, Ahmed M, Ginsburg S, Hays RD, Scleroderma Collagen Type 1 Study Group (2007) Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis. Qual Life Res 16:1083\u20131092","journal-title":"Qual Life Res"},{"key":"8636_CR136","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/rheumatology\/kep284","volume":"48","author":"D Khanna","year":"2009","unstructured":"Khanna D, Tseng CH, Furst DE, Clements PJ, Elashoff R, Roth M, Elashoff D, Tashkin DP, for Scleroderma Lung Study Investigators (2009) Minimally important differences in the Mahler\u2019s Transition Dyspnoea Index in a large randomized controlled trial\u2014results from the Scleroderma Lung Study. Rheumatology (Oxford) 48:1537\u20131540","journal-title":"Rheumatology (Oxford)"},{"key":"8636_CR137","doi-asserted-by":"crossref","unstructured":"Sekhon S, Pope J, Canadian Scleroderma Research Group, Baron M The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma. J Rheumatol 2010, 37:591\u2013598","DOI":"10.3899\/jrheum.090375"},{"key":"8636_CR138","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.3899\/jrheum.110225","volume":"38","author":"D Khanna","year":"2011","unstructured":"Khanna D, Furst DE, Maranian P, Seibold JR, Impens A, Mayes MD, Clements PJ, Getzug T, Hays RD (2011) Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. J Rheumatol 38:1920\u20131924","journal-title":"J Rheumatol"},{"key":"8636_CR139","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2217\/pme.11.7","volume":"8","author":"EO Lillie","year":"2011","unstructured":"Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ (2011) The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Per Med 8:161\u2013173","journal-title":"Per Med"},{"key":"8636_CR140","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/520609a","volume":"520","author":"NJ Schork","year":"2015","unstructured":"Schork NJ (2015) Personalized medicine: Time for one-person trials. Nature 520:609\u2013611","journal-title":"Nature"},{"key":"8636_CR141","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/amiajnl-2013-002519","volume":"21","author":"V Gardeux","year":"2014","unstructured":"Gardeux V, Achour I, Li J, Maienschein-Cline M, Li H, Pesce L, Parinandi G, Bahroos N, Winn R, Foster I, Garcia JG, Lussier YA (2014) \u2018N-of-1-pathways\u2019 unveils personal deregulated mechanisms from a single pair of RNA-Seq samples: towards precision medicine. J Am Med Inform Assoc 21:1015\u20131025","journal-title":"J Am Med Inform Assoc"},{"issue":"8","key":"8636_CR142","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1158\/1055-9965.EPI-05-0456","volume":"14","author":"CP Wild","year":"2005","unstructured":"Wild CP (2005) Complementing the genome with an \u201cexposome\u201d: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomark Prev 14(8):1847\u20131850. doi:\n                    10.1158\/1055-9965.EPI-05-0456","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"8636_CR143","doi-asserted-by":"publisher","first-page":"e2017009","DOI":"10.5620\/eht.e2017009","volume":"32","author":"Kyoung-Nam Kim","year":"2017","unstructured":"Kim KN, Hong YC (2017) The exposome and the future of epidemiology: a vision and prospect. Environ Health Toxicol. doi:\n                    10.5620\/eht.e2017009","journal-title":"Environmental Health and Toxicology"},{"issue":"2","key":"8636_CR144","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/oxfordjournals.epirev.a000804","volume":"23","author":"M Posada de la Paz","year":"2001","unstructured":"Posada de la Paz M, Philen RM, Borda AI (2001) Toxic oil syndrome: the perspective after 20 years. Epidemiol Rev 23(2):231\u2013247","journal-title":"Epidemiol Rev"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8636-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T13:43:34Z","timestamp":1552657414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8636-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,2]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["8636"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8636-1","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,2]]},"assertion":[{"value":"2 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors declare that no grants were involved in supporting this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"No ethics issues are raised and no informed consent was obtained as this is a review article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Informed Consent"}}]}}